Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department
Click here to read the clinical policy
In response to the 2013 Council and ACEP Board adopted Amended Resolution 32(13), the Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department, published in 2013 in Annals of Emergency Medicine, is being posted for a 60-day additional ACEP membership comment period. Comments received along with supporting evidence and any new evidence will be carefully reviewed and the evidence graded. References should accompany comments so that the evidence can be carefully considered and graded. Findings will be reported to the ACEP Board. Also, future clinical policy developments will include a 60-day comment period before finalization.
The link to the clinical policy is attached. Comments should be submitted by March 24, 2014. For questions, contact Rhonda Whitson, RHIA, at firstname.lastname@example.org.
Public Comment Form
Organization / Institution / Specialty
Do you have any relevant industry relationships - Relationships with companies associated with products or services that significantly impact the specific aspect of disease addressed in the tPA clinical policy that could pose a real or potential conflict of interest with respect to this guideline?
Do you have any other position, relationship, or interests that may create conflict or the appearance of conflict of interest related to IV tPA for acute ischemic stroke? (eg, author/co-author published piece on topic; regional or national speaker on topic)